D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

THRX holding history

Theseus Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

THRX overview All 13F holders of THRX Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of THRX by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−10,412−100.0%	Sold out	Holders
Q2 2022	10,412	$58.0K	<0.1%	+10,412	New	Holders
Q1 2022	0	$0	0.0%	−22,136−100.0%	Sold out	Holders
Q4 2021	22,136	$281.0K	<0.1%	+22,136	New	Holders